Can resorcinol be used to treat pesticide poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Resorcinol Has No Role in Pesticide Overdose Treatment and Is Itself a Toxin

Resorcinol should never be used to treat pesticide poisoning—it is a dermatologic agent for acne and eczema, not an antidote, and oral ingestion of resorcinol itself causes severe toxicity including seizures, metabolic acidosis, methemoglobinemia, respiratory failure, and death. 1


Why Resorcinol Is Not Used in Pesticide Poisoning

Resorcinol's Actual Indication

  • Resorcinol is a keratolytic and antiseptic agent approved exclusively for topical treatment of acne vulgaris, eczema, and psoriasis—not for systemic poisoning of any kind. 2
  • It has been studied only in dermatologic conditions such as hidradenitis suppurativa (15% cream applied to skin lesions), where it reduced abscess duration but caused frequent irritant dermatitis. 2

Resorcinol Is a Poison, Not an Antidote

  • Fatal oral ingestion of resorcinol produces unconsciousness, generalized tonic-clonic seizures, severe metabolic acidosis, leukocytosis, respiratory failure requiring mechanical ventilation, and elevated methemoglobin levels. 1
  • The clinical presentation of resorcinol poisoning itself mimics aspects of organophosphate toxicity (seizures, respiratory failure, acidosis), making it a dangerous substance to introduce in any poisoning scenario. 1

Evidence-Based Treatment of Pesticide Poisoning (Organophosphates)

Immediate Antidotal Therapy

Atropine is the first-line, gold-standard treatment with Class I, Level A evidence and no absolute contraindications. 3

  • Adults: 1–2 mg IV immediately, doubling the dose every 5 minutes until bronchorrhea, bronchospasm, and bradycardia resolve; typical cumulative requirement is 10–20 mg in the first 2–3 hours, with some patients needing up to 50 mg in 24 hours. 3, 4
  • Children: 0.02 mg/kg IV (minimum 0.1 mg, maximum 0.5 mg per dose), doubling every 5 minutes until full atropinization (clear lungs, dry skin, heart rate >80 bpm, adequate blood pressure). 3, 4
  • Atropine-induced tachycardia is expected and is NOT a contraindication to continued dosing; the therapeutic endpoint is control of life-threatening muscarinic symptoms, not heart rate. 3

Pralidoxime (2-PAM) receives a Class 2a recommendation with Level A evidence and must be given early before enzyme "aging" renders it ineffective. 3, 4

  • Adults: 1–2 g IV loading dose over 15–30 minutes, followed by continuous infusion of 400–600 mg/hour. 3, 4
  • Children: 20–50 mg/kg IV (maximum 2 g) over 15–30 minutes, followed by 10–20 mg/kg/hour continuous infusion. 3, 4
  • Do not delay pralidoxime while awaiting toxin confirmation; the organophosphate-acetylcholinesterase bond "ages" irreversibly within minutes to hours (especially with nerve agents like soman), after which oxime therapy becomes ineffective. 3

Benzodiazepines for seizures and agitation:

  • Diazepam 0.2 mg/kg IV or midazolam 0.05–0.1 mg/kg IV, repeated as needed until seizures cease. 3, 4

Decontamination (Not Resorcinol)

  • Immediate dermal decontamination: Remove all contaminated clothing and irrigate skin copiously with soap and water while wearing personal protective equipment (PPE) to prevent secondary exposure of healthcare workers. 3, 5
  • Gastric decontamination: Lavage is indicated only if ingestion occurred within 60 minutes of presentation; activated charcoal with a cathartic may be used within the same window. 5
  • Do NOT give anything by mouth (including water, milk, or activated charcoal) unless directed by poison control, as oral administration can provoke emesis and aspiration. 3

Airway Management

  • Early endotracheal intubation is recommended for life-threatening poisoning; observational data suggest better outcomes with early intubation. 3, 4
  • Avoid succinylcholine and mivacurium—these neuromuscular blockers are metabolized by cholinesterase and are contraindicated in organophosphate poisoning. 3, 4

Common Pitfalls to Avoid

Misidentifying Resorcinol as an Antidote

  • There is zero evidence in any guideline, drug label, or research study supporting resorcinol for pesticide poisoning. 2, 3, 4, 6, 7, 5, 8, 1
  • Resorcinol appears in acne treatment guidelines only as a topical keratolytic used cautiously with other irritating agents like adapalene. 2

Delaying Atropine or Pralidoxime

  • Never delay antidotal therapy to obtain cholinesterase levels or await laboratory confirmation; treatment urgency is based on clinical signs (bronchorrhea, bronchospasm, bradycardia, seizures), not laboratory values. 4, 9
  • Cholinesterase levels <50% of normal confirm exposure but normal or mildly reduced levels do not exclude clinically significant poisoning and should never be used to withhold atropine or pralidoxime. 4, 9

Inadequate Atropine Dosing

  • Aggressive escalation is required: double the atropine dose every 5 minutes (not a fixed-dose schedule) until all atropinization endpoints are met; undertreating organophosphate poisoning is far more dangerous than atropine-induced fever or tachycardia. 3, 4

Secondary Exposure of Healthcare Workers

  • Healthcare workers performing gastric lavage are at significant risk of secondary exposure from gastric contents and emesis containing organophosphates; documented cases have required atropine, pralidoxime, and intubation for 24 hours. 3
  • Never allow healthcare workers to handle gastric contents without PPE. 3

Summary Algorithm for Organophosphate Poisoning

  1. Ensure PPE for all healthcare workers to prevent secondary contamination. 3, 5
  2. Decontaminate skin immediately: remove clothing, irrigate with soap and water. 3, 5
  3. Atropine 1–2 mg IV for adults (0.02 mg/kg for children), doubling every 5 minutes until bronchorrhea, bronchospasm, and bradycardia resolve. 3, 4
  4. Pralidoxime 1–2 g IV loading dose for adults (20–50 mg/kg for children) over 15–30 minutes, then continuous infusion at 400–600 mg/hour (10–20 mg/kg/hour for children). 3, 4
  5. Benzodiazepines (diazepam 0.2 mg/kg or midazolam 0.05–0.1 mg/kg) for seizures or agitation. 3, 4
  6. Early intubation for life-threatening poisoning; avoid succinylcholine and mivacurium. 3, 4
  7. Monitor for 48–72 hours for intermediate syndrome (proximal muscle weakness 24–96 hours post-exposure) and delayed polyneuropathy (1–3 weeks later). 4, 9, 8

Resorcinol has no place in this algorithm and should never be considered for pesticide poisoning. 1

References

Research

A case report of fatal oral ingestion of resorcinol.

The Mount Sinai journal of medicine, New York, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Organophosphorus Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Organophosphate Poisoning: Evidence‑Based Clinical Management and Role of Cholinesterase Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Recognition and management of acute pesticide poisoning.

American family physician, 2002

Research

Pesticide poisoning.

The National medical journal of India, 2007

Guideline

Chronic Neuropsychiatric Sequelae and Limitations of Cholinesterase Monitoring in Organophosphate Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.